Open access
Open access
Powered by Google Translator Translator

Gastroenterology

Guideline | Endoscopic tissue sampling – Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts.

26 Nov, 2021 | 09:41h | UTC

Endoscopic tissue sampling – Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Endoscopy

 

Guideline | Endoscopic tissue sampling – Part 2: Lower gastrointestinal tract.

26 Nov, 2021 | 09:39h | UTC

Endoscopic tissue sampling – Part 2: Lower gastrointestinal tract. European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Endoscopy

 

M-A: Incidence, prevalence and determinants of discomfort in inflammatory bowel disease.

25 Nov, 2021 | 09:54h | UTC

Systematic Review and Meta-analysis on the Incidence, Prevalence and Determinants of Discomfort in Inflammatory Bowel Disease – Journal of the Canadian Association of Gastroenterology

 

AGA Clinical practice update on management of chronic gastrointestinal pain in disorders of gut–brain interaction.

24 Nov, 2021 | 08:42h | UTC

AGA Clinical Practice Update on Management of Chronic Gastrointestinal Pain in Disorders of Gut–Brain Interaction: Expert Review – Clinical Gastroenterology and Hepatology

 

Systematic Review: Vaccines for preventing rotavirus diarrhea.

24 Nov, 2021 | 08:20h | UTC

Vaccines for preventing rotavirus diarrhoea: vaccines in use – Cochrane Library

Summary: Are rotavirus vaccines safe and effective in preventing rotavirus diarrhoea in infants and children? – Cochrane Library

Commentary: Vaccines for preventing rotavirus diarrhoea: an updated Cochrane review – Cochrane Library

 

ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.

23 Nov, 2021 | 08:40h | UTC

ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease – American Journal of Gastroenterology

 

Commentary on Twitter (thread – click for more)

 

RCT: Educating outpatients for bowel preparation before colonoscopy using virtual reality videos improved bowel preparation, polyp and adenoma detection rates, and improved compliance and satisfaction.

23 Nov, 2021 | 08:28h | UTC

Educating Outpatients for Bowel Preparation Before Colonoscopy Using Conventional Methods vs Virtual Reality Videos Plus Conventional MethodsA Randomized Clinical Trial – JAMA Network Open

 

Commentary on Twitter

 

Consensus Statement: U.S. Multi-Society Task Force on Colorectal Cancer now suggests average-risk CRC screening begins at age 45.

21 Nov, 2021 | 23:01h | UTC

Updates on Age to Start and Stop Colorectal Cancer Screening: Recommendations From the U.S. Multi-Society Task Force on Colorectal Cancer – Gastroenterology

News release: US Multi-Society Task Force on colorectal cancer releases updated screening recommendations - American Gastroenterological Association

Related:

State of the Art Review: Screening and prevention of colorectal cancer.

USPSTF Statement: Start colorectal cancer screening at 45 years for most patients.

ACG Clinical Guidelines: Start colorectal cancer screening at 45

 

Clinical Guideline Highlights for the Hospitalist: Management of Upper Gastrointestinal and Ulcer Bleeding.

21 Nov, 2021 | 22:44h | UTC

Clinical Guideline Highlights for the Hospitalist: Management of Upper Gastrointestinal and Ulcer Bleeding – Journal of Hospital Medicine (free for a limited period)

Original Guideline: ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding – RBC transfusion at a threshold of 7 g/dL; Erythromycin infusion is suggested before endoscopy; and endoscopy is suggested within 24 hours after presentation.

 

Review and algorithm: Dysphagia aortica.

16 Nov, 2021 | 08:19h | UTC

Dysphagia aortica – European Surgery

 

Cohort study: In patients with nonalcoholic steatohepatitis and obesity, bariatric surgery was associated with lower risk of incident major adverse liver outcomes and major adverse cardiovascular events.

12 Nov, 2021 | 10:24h | UTC

Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis – JAMA (free for a limited period)

Editorial: Bariatric Surgery as a Strategy for Improving Outcomes in Nonalcoholic Steatohepatitis – JAMA (free for a limited period)

 

Commentary on Twitter

 

Consensus Statement: Advancing the global public health agenda for non-alcoholic fatty liver disease.

11 Nov, 2021 | 08:48h | UTC

Advancing the global public health agenda for NAFLD: a consensus statement – Nature Reviews Gastroenterology & Hepatology

Related:

Clinical Care Pathway for the Risk Stratification and Management of Patients with Nonalcoholic Fatty Liver Disease.

Non-alcoholic fatty liver disease: A patient guideline.

State of the art review: Management of non-alcoholic fatty liver disease

M-A: Non-alcoholic fatty liver disease linked to increased risk of fatal and non-fatal cardiovascular events.

M-A: non-invasive tests for advanced fibrosis can reduce the need for biopsy in patients with non-alcoholic fatty liver disease.

Review: Dietary carbohydrates and fats in nonalcoholic fatty liver disease.

 

Commentary on Twitter

 

RCT: One-time flexible sigmoidoscopy screening is associated with long-term reduction in colorectal cancer incidence and mortality.

10 Nov, 2021 | 07:04h | UTC

Long-Term Follow-up of the Italian Flexible Sigmoidoscopy Screening Trial – Annals of Internal Medicine

Commentaries:

Flexible sigmoidoscopy associated with long-term reduction in colorectal cancer incidence, mortality – ACP Internist

Flexible sigmoidoscopy screening associated with long-term reduction in colorectal cancer incidence and mortality – American College of Physicians

 

Clinical Care Pathway for the Risk Stratification and Management of Patients with Nonalcoholic Fatty Liver Disease.

5 Nov, 2021 | 09:50h | UTC

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease – Gastroenterology

News release: International experts develop Clinical Care Pathway in response to NASH epidemic – American Gastroenterology Association

Related:

Non-alcoholic fatty liver disease: A patient guideline.

State of the art review: Management of non-alcoholic fatty liver disease

M-A: Non-alcoholic fatty liver disease linked to increased risk of fatal and non-fatal cardiovascular events.

M-A: non-invasive tests for advanced fibrosis can reduce the need for biopsy in patients with non-alcoholic fatty liver disease.

Review: Dietary carbohydrates and fats in nonalcoholic fatty liver disease.

 

Review: Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation.

3 Nov, 2021 | 09:45h | UTC

Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation – Nature Reviews Gastroenterology & Hepatology

 

Commentary on Twitter

 

Consensus Statement: Preoperative management of gastrointestinal and pulmonary medications.

2 Nov, 2021 | 02:53h | UTC

Preoperative Management of Gastrointestinal and Pulmonary Medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement – Mayo Clinic Proceedings

Related articles from Mayo Clinic Proceedings:

Consensus Statement: Preoperative management of endocrine, hormonal, and urologic medications

Consensus statement: Preoperative management of opioid and nonopioid analgesics

Perioperative evaluation and management of patients with diabetes, thyroid disease, and adrenal insufficiency. Use of insulin and noninsulin diabetic medications, management of hyper and hypothyroidism, and use of stress-dose corticosteroids are some of the subjects reviewed

Review: Preoperative Cardiac Risk Assessment

Review | Perioperative cardiac risk reduction in noncardiac surgery.

Systematic Review of Perioperative Cardiac Risk Prediction Indices

Review: Perioperative venous thromboembolism prophylaxis

 

Short Review: Metronidazole-induced neurotoxicity.

2 Nov, 2021 | 02:41h | UTC

Metronidazole-induced neurotoxicity – Canadian medical Association Journal

 

Commentary on Twitter

 

Review: Clinical management of pancreatic premalignant lesions.

31 Oct, 2021 | 19:56h | UTC

Clinical Management of Pancreatic Premalignant Lesions – Gastroenterology

 

AGA Clinical Practice Update on Endoscopic Management of Perforations in Gastrointestinal Tract.

27 Oct, 2021 | 01:35h | UTC

AGA Clinical Practice Update on Endoscopic Management of Perforations in Gastrointestinal Tract: Expert Review – Clinical Gastroenterology and Hepatology

 

UEG Consensus on Functional Dyspepsia.

27 Oct, 2021 | 01:32h | UTC

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia – UEG Journal

 

RCT: Ozanimod as induction and maintenance therapy for ulcerative colitis.

27 Oct, 2021 | 01:19h | UTC

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis – New England Journal of Medicine

 

Commentary on Twitter

 

Podcast: Diagnosis and treatment of Celiac Disease.

19 Oct, 2021 | 08:54h | UTC

#300 Celiac Disease with Dr. Amy Oxentenko – The Curbsiders

 

Guidelines for the surgical management of ulcerative colitis.

17 Oct, 2021 | 21:21h | UTC

The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Ulcerative Colitis – Diseases of the Colon & Rectum

 

Commentary on Twitter

 

RCT: FODMAPs, but not gluten, elicit modest symptoms of irritable bowel syndrome.

13 Oct, 2021 | 01:25h | UTC

FODMAPs, but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial – American Journal of Clinical Nutrition

 

Commentary on Twitter

 

ACG Clinical Guidelines: Management of Benign Anorectal Disorders

10 Oct, 2021 | 21:29h | UTC

ACG Clinical Guidelines: Management of Benign Anorectal Disorders – The American Journal of Gastroenterology

 

Commentary on Twitter

 

Stay Updated in Your Specialty

No spam, just news.